{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:28:30Z","timestamp":1791390510957,"version":"4.3.3"},"reference-count":178,"publisher":"China Science Publishing & Media Ltd.","issue":"1","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.3724\/abbs.2021001","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T08:05:52Z","timestamp":1640333152000},"page":"12-24","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for<?A3B2 ACK?>small-molecule drugs"],"prefix":"10.3724","volume":"54","author":[{"given":"Fengwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"Evans RM","year":"2014","unstructured":"Evans RM, Mangelsdorf DJ. Nuclear receptors, RXR, and the big bang. Cell, 2014, 157: 255-266.","journal-title":"Cell"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JME-13-0173","volume":"51","author":"Rastinejad F","year":"2013","unstructured":"Rastinejad F, Huang P, Chandra V, Khorasanizadeh S. Understanding nuclear receptor form and function using structural biology. J Mol Endocrinol, 2013, 51: T1-T21.","journal-title":"J Mol Endocrinol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"Santos R","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP. A comprehensive map of molecular drug targets. Nat Rev Drug Discov, 2017, 16: 19-34.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION4","doi-asserted-by":"crossref","unstructured":"Porter BA, Ortiz MA, Bratslavsky G, Kotula L. Structure and function of the nuclear receptor superfamily and current targeted therapies of prostate cancer. Cancers (Basel) 2019, 11: 1852.","DOI":"10.3390\/cancers11121852"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nrd1551","volume":"3","author":"Gronemeyer H","year":"2004","unstructured":"Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov, 2004, 3: 950-964.","journal-title":"Nat Rev Drug Discov"},{"key":"CITATION6","doi-asserted-by":"crossref","unstructured":"Schellhammer PF. An evaluation of bicalutamide in the treatment of prostate cancer. Expert Opin Pharmacother 2002, 3: 1313\u20131328.","DOI":"10.1517\/14656566.3.9.1313"},{"key":"CITATION7","doi-asserted-by":"crossref","unstructured":"See WA, Tyrrell CJ; CASODEX Early Prostate Cancer Trialists\u2019 Group. The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer. J Cancer Res Clin Oncol 2006, 132: S7\u2013S16.","DOI":"10.1007\/s00432-006-0132-6"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2133.2007.07975.x","volume":"157","author":"Gniadecki R","year":"2007","unstructured":"Gniadecki R, Assaf C, Bagot M, Dummer R, Duvic M, Knobler R, Ranki A, Schwandt P, Whittaker S. The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol, 2007, 157: 433-440.","journal-title":"Br J Dermatol"},{"key":"CITATION9","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhou H, Su Y. Targeting truncated RXR\u03b1 for cancer therapy. Acta Biochim Biophys Sin 2016, 48: 49\u201359.","DOI":"10.1093\/abbs\/gmv104"},{"key":"CITATION10","doi-asserted-by":"crossref","unstructured":"Elix C, Pal SK, Jones JO. The role of peroxisome proliferator-activated receptor gamma in prostate cancer. Asian J Androl 2018, 20: 238\u2013243.","DOI":"10.4103\/aja.aja_15_17"},{"key":"CITATION11","doi-asserted-by":"crossref","unstructured":"Ishigami-Yuasa M, Kagechika H. Chemical screening of nuclear receptor modulators.  Int J Mol Sci 2020, 21: 5512.","DOI":"10.3390\/ijms21155512"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S0039-128X(99)00014-8","volume":"64","author":"Kumar R","year":"1999","unstructured":"Kumar R, Thompson EB. The structure of the nuclear hormone receptors. Steroids, 1999, 64: 310-319.","journal-title":"Steroids"},{"key":"CITATION13","doi-asserted-by":"crossref","unstructured":"Thomson SA,  Baldwin WS,  Wang YH, Kwon G, Leblanc GA. Annotation, phylogenetics, and expression of the nuclear receptors in Daphnia pulex.  BMC Genomics 2009, 10: 500.","DOI":"10.1186\/1471-2164-10-500"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1021\/jm021080f","volume":"46","author":"Ye L","year":"2003","unstructured":"Ye L, Li YL, Mellstr\u00f6m K, Mellin C, Bladh LG, Koehler K, Garg N, Garcia Collazo AM, Litten C, Husman B, Persson K, Ljunggren J, Grover G, Sleph PG, George R, Malm J. Thyroid receptor ligands. 1. agonist ligands selective for the thyroid receptor \u03b21. J Med Chem, 2003, 46: 1580-1588.","journal-title":"J Med Chem"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1210\/me.2013-1359","volume":"28","author":"Souza PCT","year":"2014","unstructured":"Souza PCT, Puhl AC, Mart\u00ednez L, Apar\u00edcio R, Nascimento AS, Figueira ACM, Nguyen P, Webb P, Skaf MS, Polikarpov I. Identification of a new hormone-binding site on the surface of thyroid hormone receptor. Mol Endocrinol, 2014, 28: 534-545.","journal-title":"Mol Endocrinol"},{"key":"CITATION16","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez L, Nascimento AS, Nunes FM, Phillips K, Aparicio R, Dias SM, Figueira AC, et al. Gaining ligand selectivity in thyroid hormone receptors via entropy. Proc Natl Acad Sci U S A  2009, 106: 20717-20722.","DOI":"10.1073\/pnas.0911024106"},{"key":"CITATION17","doi-asserted-by":"crossref","unstructured":"Rastinejad F, Perlmann T, Evans RM, Sigler PB. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995, 375: 203\u2013211.","DOI":"10.1038\/375203a0"},{"key":"CITATION18-1","doi-asserted-by":"crossref","unstructured":"Borngraeber S, Budny MJ, Chiellini G, Cunha-Lima ST, Togashi M, Webb P, Baxter JD, et al. Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor. Proc Natl Acad Sci U S A 2003, 100: 15358-15363.","DOI":"10.1073\/pnas.2136689100"},{"key":"CITATION19","doi-asserted-by":"crossref","unstructured":"Yao B, Wei Y, Zhang S, Tian S, Xu S, Wang R, Zheng W, et al. Revealing a mutant-Induced receptor allosteric mechanism for the thyroid hormone resistance. iScience 2019, 20: 489\u2013496.","DOI":"10.1016\/j.isci.2019.10.002"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1038\/ncomms9013","volume":"6","author":"Kojetin DJ","year":"2015","unstructured":"Kojetin DJ, Matta-Camacho E, Hughes TS, Srinivasan S, Nwachukwu JC, Cavett V, Nowak J, Chalmers MJ, Marciano DP, Kamenecka TM, Shulman AI, Rance M, Griffin PR, Bruning JB, Nettles KW. Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun, 2015, 6:","journal-title":"Nat Commun"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/emboj\/19.5.1045","volume":"19","author":"Rastinejad F","year":"2000","unstructured":"Rastinejad F, Wagner T, Zhao Q, Khorasanizadeh S. Structure of the RXR\u2013RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J, 2000, 19: 1045-1054.","journal-title":"EMBO J"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1097-2765(00)80424-4","volume":"5","author":"Bourguet W","year":"2000","unstructured":"Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell, 2000, 5: 289-298.","journal-title":"Mol Cell"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"9969","DOI":"10.1093\/nar\/gkaa697","volume":"48","author":"Osz J","year":"2020","unstructured":"Osz J, McEwen AG, Bourguet M, Przybilla F, Peluso-Iltis C, Poussin-Courmontagne P, M\u00e9ly Y, Cianf\u00e9rani S, Jeffries CM, Svergun DI, Rochel N. Structural basis for DNA recognition and allosteric control of the retinoic acid receptors RAR\u2013RXR. Nucleic Acids Res, 2020, 48: 9969-9985.","journal-title":"Nucleic Acids Res"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00242472","volume":"3","author":"Knegtel RM","year":"1993","unstructured":"Knegtel RM, Katahira M, Schilthuis JG, Bonvin AM, Boelens R, Eib D, van der Saag PT, Kaptein R. The solution structure of the human retinoic acid receptor-\u03b2 DNA-binding domain. J Biomol NMR, 1993, 3: 1-17.","journal-title":"J Biomol NMR"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.embor.7400235","volume":"5","author":"Germain P","year":"2004","unstructured":"Germain P, Kammerer S, P\u00e9rez E, Peluso-Iltis C, Tortolani D, Zusi FC, Starrett J, Lapointe P, Daris JP, Marinier A, de Lera AR, Rochel N, Gronemeyer H. Rational design of RAR\u2010selective ligands revealed by RAR\u03b2 crystal stucture. EMBO Rep, 2004, 5: 877-882.","journal-title":"EMBO Rep"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41467-017-00981-y","volume":"8","author":"Chandra V","year":"2017","unstructured":"Chandra V, Wu D, Li S, Potluri N, Kim Y, Rastinejad F. The quaternary architecture of RAR\u03b2\u2013RXR\u03b1 heterodimer facilitates domain\u2013domain signal transmission. Nat Commun, 2017, 8:","journal-title":"Nat Commun"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/378681a0","volume":"378","author":"Renaud JP","year":"1995","unstructured":"Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D. Crystal structure of the RAR-\u03b3 ligand-binding domain bound to all-trans retinoic acid. Nature, 1995, 378: 681-689.","journal-title":"Nature"},{"key":"CITATION28","doi-asserted-by":"crossref","unstructured":"Thoreau E, Arlabosse JM, Bouix-Peter C, Chambon S, Chantalat L, Daver S, Dumais L, et al. Structure-based design of Trifarotene (CD5789): a potent and selective RAR\u03b3 agonist for the treatment of acne. Bioorganic Bioorg Med Chem Lett 2018, 28: 1736\u20131741.","DOI":"10.1016\/j.bmcl.2018.04.036"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"13919","DOI":"10.1073\/pnas.241410198","volume":"98","author":"Xu HE","year":"2001","unstructured":"Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe Robert T. J, McKee DD, Moore JT, Willson TM. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A, 2001, 98: 13919-13924.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/415813a","volume":"415","author":"Xu HE","year":"2002","unstructured":"Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR\u03b1. Nature, 2002, 415: 813-817.","journal-title":"Nature"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"101727","DOI":"10.1016\/j.isci.2020.101727","volume":"23","author":"Kamata S","year":"2020","unstructured":"Kamata S, Oyama T, Saito K, Honda A, Yamamoto Y, Suda K, Ishikawa R, Itoh T, Watanabe Y, Shibata T, Uchida K, Suematsu M, Ishii I. Ppar\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates. iScience, 2020, 23:","journal-title":"iScience"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1097-2765(00)80467-0","volume":"3","author":"Xu HE","year":"1999","unstructured":"Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV. Molecular recognition of fatty acids by peroxisome proliferator\u2013activated receptors. Mol Cell, 1999, 3: 397-403.","journal-title":"Mol Cell"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1021\/acsmedchemlett.8b00287","volume":"9","author":"Lagu B","year":"2018","unstructured":"Lagu B, Kluge AF, Tozzo E, Fredenburg R, Bell EL, Goddeeris MM, Dwyer P, Basinski A, Senaiar RS, Jaleel M, Tiwari NK, Panigrahi SK, Krishnamurthy NR, Takahashi T, Patane MA. Selective PPAR\u03b4 modulators improve mitochondrial function: potential treatment for duchenne muscular dystrophy (DMD). ACS Med Chem Lett, 2018, 9: 935-940.","journal-title":"ACS Med Chem Lett"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1073\/pnas.96.11.6102","volume":"96","author":"Oberfield JL","year":"1999","unstructured":"Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM. A peroxisome proliferator-activated receptor   ligand inhibits adipocyte differentiation. Proc Natl Acad Sci U S A, 1999, 96: 6102-6106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/25931","volume":"395","author":"Nolte RT","year":"1998","unstructured":"Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-\u03b3. Nature, 1998, 395: 137-143.","journal-title":"Nature"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41467-020-14750-x","volume":"11","author":"Shang J","year":"2020","unstructured":"Shang J, Mosure SA, Zheng J, Brust R, Bass J, Nichols A, Solt LA, Griffin PR, Kojetin DJ. A molecular switch regulating transcriptional repression and activation of PPAR\u03b3. Nat Commun, 2020, 11:","journal-title":"Nat Commun"},{"key":"CITATION37","doi-asserted-by":"crossref","unstructured":"Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris LL, et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct Mol Biol 2007, 14: 1207\u20131213.","DOI":"10.1038\/nsmb1344"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1097-2765(00)80084-2","volume":"1","author":"Zhao Q","year":"1998","unstructured":"Zhao Q, Khorasanizadeh S, Miyoshi Y, Lazar MA, Rastinejad F. Structural elements of an orphan nuclear receptor\u2013DNA complex. Mol Cell, 1998, 1: 849-861.","journal-title":"Mol Cell"},{"key":"CITATION39","doi-asserted-by":"crossref","unstructured":"Phelan CA, Gampe RT, Lambert MH, Parks DJ, Montana V, Bynum J, Broderick TM, et al. Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. Nat Struct Mol Biol 2010, 17: 808\u2013814.","DOI":"10.1038\/nsmb.1860"},{"key":"CITATION40","doi-asserted-by":"crossref","unstructured":"Mosure SA, Strutzenberg TS, Shang J, Munoz-Tello P, Solt LA, Griffin PR, Kojetin DJ. Structural basis for heme-dependent NCoR binding to the transcriptional repressor REV-ERB\u03b2. Sci Adv 2021, 7: eabc6479.","DOI":"10.1126\/sciadv.abc6479"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jmb.2007.08.037","volume":"373","author":"Woo EJ","year":"2007","unstructured":"Woo EJ, Jeong DG, Lim MY, Jun Kim S, Kim KJ, Yoon SM, Park BC, Eon Ryu S. Structural insight into the constitutive repression function of the nuclear receptor REV-ERB\u03b2. J Mol Biol, 2007, 373: 735-744.","journal-title":"J Mol Biol"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cmet.2015.01.004","volume":"21","author":"Santori FR","year":"2015","unstructured":"Santori FR, Huang P, van de Pavert SA, Douglass Jr. EF, Leaver DJ, Haubrich BA, Keber R, Lorbek G, Konijn T, Rosales BN, Rozman D, Horvat S, Rahier A, Mebius RE, Rastinejad F, Nes WD, Littman DR. Identification of natural ROR\u03b3 ligands that regulate the development of lymphoid cells. Cell Metab, 2015, 21: 286-298.","journal-title":"Cell Metab"},{"key":"CITATION43","doi-asserted-by":"crossref","unstructured":"Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I, Fournier B. X-ray structure of the hRORalpha LBD at 1.63 \u00c5: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 2002, 10: 1697\u20131707.","DOI":"10.1016\/S0969-2126(02)00912-7"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.1074\/jbc.M400302200","volume":"279","author":"Kallen J","year":"2004","unstructured":"Kallen J, Schlaeppi JM, Bitsch F, Delhon I, Fournier B. Crystal structure of the human ROR\u03b1 ligand binding domain in complex with cholesterol sulfate at 2.2 \u00c5. J Biol Chem, 2004, 279: 14033-14038.","journal-title":"J Biol Chem"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1093\/emboj\/20.21.5822","volume":"20","author":"Stehlin C","year":"2001","unstructured":"Stehlin C, Wurtz JM, Steinmetz A, Greiner E, Sch\u00fcle R, Moras D, Renaud JP. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J, 2001, 20: 5822-5831.","journal-title":"EMBO J"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nsb979","volume":"10","author":"Stehlin-Gaon C","year":"2003","unstructured":"Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Sch\u00fcle R. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR\u03b2. Nat Struct Mol Biol, 2003, 10: 820-825.","journal-title":"Nat Struct Mol Biol"},{"key":"CITATION47","doi-asserted-by":"crossref","unstructured":"de Vries RM, Meijer FA, Doveston RG, Leijten-van de Gevel IA, Brunsveld L. Cooperativity between the orthosteric and allosteric ligand binding sites of ROR\u03b3t. Proc Natl Acad Sci U S A 2021, 118: e2021287118.","DOI":"10.1073\/pnas.2021287118"},{"key":"CITATION48","doi-asserted-by":"crossref","unstructured":"Jin L, Martynowski D, Zheng S, Wada T, Xie W, Li Y. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. Mol Endocrinol 2010, 24: 923\u2013929.","DOI":"10.1210\/me.2009-0507"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1093\/emboj\/cdg456","volume":"22","author":"Svensson S","year":"2003","unstructured":"Svensson S, Ostberg T, Jacobsson M, Norstr\u00f6m C, Stefansson K, Hall\u00e9n D, Johansson IC, Zachrisson K, Ogg D, Jendeberg L. Crystal structure of the heterodimeric complex of LXR  and RXR  ligand-binding domains in a fully agonistic conformation. EMBO J, 2003, 22: 4625-4633.","journal-title":"EMBO J"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1021\/acs.jmedchem.6b00176","volume":"59","author":"Stachel SJ","year":"2016","unstructured":"Stachel SJ, Zerbinatti C, Rudd MT, Cosden M, Suon S, Nanda KK, Wessner K, DiMuzio J, Maxwell J, Wu Z, Uslaner JM, Michener MS, Szczerba P, Brnardic E, Rada V, Kim Y, Meissner R, Wuelfing P, Yuan Y, Ballard J, Holahan M, Klein DJ, Lu J, Fradera X, Parthasarathy G, Uebele VN, Chen Z, Li Y, Li J, Cooke AJ, Bennett DJ, Bilodeau MT, Renger J. Identification and in vivo evaluation of liver X receptor \u03b2-selective agonists for the potential treatment of alzheimer\u2019s disease. J Med Chem, 2016, 59: 3489-3498.","journal-title":"J Med Chem"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"27138","DOI":"10.1074\/jbc.M302260200","volume":"278","author":"Williams S","year":"2003","unstructured":"Williams S, Bledsoe RK, Collins JL, Boggs S, Lambert MH, Miller AB, Moore J, McKee DD, Moore L, Nichols J, Parks D, Watson M, Wisely B, Willson TM. X-ray crystal structure of the liver x receptor \u03b2 ligand binding domain. J Biol Chem, 2003, 278: 27138-27143.","journal-title":"J Biol Chem"},{"key":"CITATION52","doi-asserted-by":"crossref","unstructured":"Lou X, Toresson G, Benod C,  Suh JH, Philips KJ, Webb P, Gustafsson JA. Structure of the retinoid X receptor \u03b1-liver X receptor \u03b2 (RXR\u03b1-LXR\u03b2) heterodimer on DNA. Nat Struct Mol Biol 2014, 21: 277\u2013281.","DOI":"10.1038\/nsmb.2778"},{"key":"CITATION53","doi-asserted-by":"crossref","unstructured":"Chen H, Chen Z, Zhang Z, Li Y,  Zhang S,  Jiang F, Wei J, et al. Discovery of new LXR\u03b2 agonists as glioblastoma inhibitors. Eur J Med Chem 2020, 194: 112240.","DOI":"10.1016\/j.ejmech.2020.112240"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S1097-2765(03)00104-7","volume":"11","author":"Downes M","year":"2003","unstructured":"Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, Rosenfeld JM, Alvarez JGA, Noel JP, Nicolaou KC, Evans RM. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell, 2003, 11: 1079-1092.","journal-title":"Mol Cell"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"18180","DOI":"10.1074\/jbc.RA118.004652","volume":"293","author":"Wang N","year":"2018","unstructured":"Wang N, Zou Q, Xu J, Zhang J, Liu J. Ligand binding and heterodimerization with retinoid X receptor \u03b1 (RXR\u03b1) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding. J Biol Chem, 2018, 293: 18180-18191.","journal-title":"J Biol Chem"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1021\/acs.jmedchem.0c01420","volume":"64","author":"Sasaki H","year":"2021","unstructured":"Sasaki H, Masuno H, Kawasaki H, Yoshihara A, Numoto N, Ito N, Ishida H, Yamamoto K, Hirata N, Kanda Y, Kawachi E, Kagechika H, Tanatani A. Lithocholic acid derivatives as potent vitamin d receptor agonists. J Med Chem, 2021, 64: 516-526.","journal-title":"J Med Chem"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/emboj\/21.9.2242","volume":"21","author":"Shaffer PL","year":"2002","unstructured":"Shaffer PL, Gewirth DT. Structural basis of VDR-DNA interactions on direct repeat response elements. EMBO J, 2002, 21: 2242-2252.","journal-title":"EMBO J"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1021\/bi036056y","volume":"43","author":"Vanhooke JL","year":"2004","unstructured":"Vanhooke JL, Benning MM, Bauer CB, Pike JW, DeLuca HF. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry, 2004, 43: 4101-4110.","journal-title":"Biochemistry"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jsbmb.2004.03.084","volume":"89-90","author":"Shaffer PL","year":"2004","unstructured":"Shaffer PL, Gewirth DT. Structural analysis of RXR\u2013VDR interactions on DR3 DNA. J Steroid Biochem Mol Biol, 2004, 89-90: 215-219.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"CITATION60","doi-asserted-by":"crossref","unstructured":"Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001, 292: 2329\u20132333.","DOI":"10.1126\/science.1060762"},{"key":"CITATION61","doi-asserted-by":"crossref","unstructured":"Delfosse V, Huet T, Harrus D, Granell M, Bourguet M,  Gardia-Par\u00e8ge C, Chiavarina B, et al. Mechanistic insights into the synergistic activation of the RXR-PXR heterodimer by endocrine disruptor mixtures. Proc Natl Acad Sci U S A 2021, 118: e2020551118.","DOI":"10.1073\/pnas.2020551118"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41467-017-00780-5","volume":"8","author":"Lin W","year":"2017","unstructured":"Lin W, Wang YM, Chai SC, Lv L, Zheng J, Wu J, Zhang Q, Wang YD, Griffin PR, Chen T. SPA70 is a potent antagonist of human pregnane X receptor. Nat Commun, 2017, 8:","journal-title":"Nat Commun"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.molcel.2004.11.036","volume":"16","author":"Suino K","year":"2004","unstructured":"Suino K, Peng L, Reynolds R, Li Y, Cha JY, Repa JJ, Kliewer SA, Xu HE. The nuclear xenobiotic receptor CAR. Mol Cell, 2004, 16: 893-905.","journal-title":"Mol Cell"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.molcel.2004.11.042","volume":"16","author":"Xu RX","year":"2004","unstructured":"Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT. A structural basis for constitutive activity in the human CAR\/RXR\u03b1 heterodimer. Mol Cell, 2004, 16: 919-928.","journal-title":"Mol Cell"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature11966","volume":"495","author":"Chandra V","year":"2013","unstructured":"Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F. Multidomain integration in the structure of the HNF-4\u03b1 nuclear receptor complex. Nature, 2013, 495: 394-398.","journal-title":"Nature"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"37973","DOI":"10.1074\/jbc.C200420200","volume":"277","author":"Dhe-Paganon S","year":"2002","unstructured":"Dhe-Paganon S, Duda K, Iwamoto M, Chi YI, Shoelson SE. Crystal structure of the HNF4\u03b1 ligand binding domain in complex with endogenous fatty acid ligand. J Biol Chem, 2002, 277: 37973-37976.","journal-title":"J Biol Chem"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"13983","DOI":"10.1074\/jbc.RA119.009558","volume":"294","author":"Han EH","year":"2019","unstructured":"Han EH, Singh P, Lee IK, Urrutia R, Chi YI. ErbB3-binding protein 1 (EBP1) represses HNF4\u03b1-mediated transcription and insulin secretion in pancreatic \u03b2-cells. J Biol Chem, 2019, 294: 13983-13994.","journal-title":"J Biol Chem"},{"key":"CITATION68","doi-asserted-by":"crossref","unstructured":"Wisely GB, Miller AB, Davis RG, Thornquest AD Jr, Johnson R, Spitzer T, Sefler A, et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 2002, 10: 1225\u20131234.","DOI":"10.1016\/S0969-2126(02)00829-8"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/375203a0","volume":"375","author":"Rastinejad F","year":"1995","unstructured":"Rastinejad F, Perlmann T, Evans RM, Sigler PB. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature, 1995, 375: 203-211.","journal-title":"Nature"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07413","volume":"456","author":"Chandra V","year":"2008","unstructured":"Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F. Structure of the intact PPAR-\u03b3\u2013RXR-\u03b1 nuclear receptor complex on DNA. Nature, 2008, 456: 350-356.","journal-title":"Nature"},{"key":"CITATION71","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/acs.jmedchem.0c01354","volume":"64","author":"Watanabe M","year":"2021","unstructured":"Watanabe M, Fujihara M, Motoyama T, Kawasaki M, Yamada S, Takamura Y, Ito S, Makishima M, Nakano S, Kakuta H. Discovery of a \u201cgatekeeper\u201d antagonist that blocks entry pathway to retinoid X receptors (RXRs) without allosteric ligand inhibition in permissive RXR heterodimers. J Med Chem, 2021, 64: 430-439.","journal-title":"J Med Chem"},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"11385","DOI":"10.1074\/jbc.M110869200","volume":"277","author":"Love JD","year":"2002","unstructured":"Love JD, Gooch JT, Benko S, Li C, Nagy L, Chatterjee VKK, Evans RM, Schwabe JWR. The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12. J Biol Chem, 2002, 277: 11385-11391.","journal-title":"J Biol Chem"},{"key":"CITATION73","doi-asserted-by":"crossref","unstructured":"Chaikuad A, Pollinger J, R\u00fchl M, Ni X, Kilu W, Heering J, Merk D. Comprehensive set of tertiary complex structures and palmitic acid binding provide molecular insights into ligand design for RXR isoforms. Int J Mol Sci 2020, 21: 8457.","DOI":"10.3390\/ijms21228457"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1074\/jbc.M110.168740","volume":"286","author":"Zhou XE","year":"2011","unstructured":"Zhou XE, Suino-Powell KM, Xu Y, Chan CW, Tanabe O, Kruse SW, Reynolds R, Engel JD, Xu HE. The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. J Biol Chem, 2011, 286: 2877-2885.","journal-title":"J Biol Chem"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"e74359","DOI":"10.1371\/journal.pone.0074359","volume":"8","author":"Tan MHE","year":"2013","unstructured":"Tan MHE, Zhou XE, Soon FF, Li X, Li J, Yong EL, Melcher K, Xu HE. The crystal structure of the orphan nuclear receptor NR2E3\/PNR ligand binding domain reveals a dimeric auto-repressed conformation. PLoS ONE, 2013, 8:","journal-title":"PLoS ONE"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1371\/journal.pbio.0060227","volume":"6","author":"Kruse SW","year":"2008","unstructured":"Kruse SW, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, Vonrhein C, Xu Y, Wang L, Tsai SY, Tsai MJ, Xu HE. Identification of COUP-TFII orphan nuclear receptor as a retinoic acid\u2013activated receptor. PLoS Biol, 2008, 6:","journal-title":"PLoS Biol"},{"key":"CITATION77","doi-asserted-by":"crossref","unstructured":"Bosica F, Andrei SA, Neves JF, Brandt P, Gunnarsson A, Landrieu I, Ottmann C, et al. Design of drug-like protein-protein interaction stabilizers guided by chelation-controlled bioactive conformation stabilization. Chemistry 2020, 26: 7131-7139.","DOI":"10.1002\/chem.202001608"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1021\/jacs.8b11658","volume":"141","author":"Sijbesma E","year":"2019","unstructured":"Sijbesma E, Hallenbeck KK, Leysen S, de Vink PJ, Sk\u00f3ra L, Jahnke W, Brunsveld L, Arkin MR, Ottmann C. Site-directed fragment-based screening for the discovery of protein\u2013protein interaction stabilizers. J Am Chem Soc, 2019, 141: 3524-3531.","journal-title":"J Am Chem Soc"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nchembio.76","volume":"4","author":"Nettles KW","year":"2008","unstructured":"Nettles KW, Bruning JB, Gil G, Nowak J, Sharma SK, Hahm JB, Kulp K, Hochberg RB, Zhou H, Katzenellenbogen JA, Katzenellenbogen BS, Kim Y, Joachimiak A, Greene GL. NF\u03baB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol, 2008, 4: 241-247.","journal-title":"Nat Chem Biol"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0092-8674(93)90390-C","volume":"75","author":"Schwabe JWR","year":"1993","unstructured":"Schwabe JWR, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell, 1993, 75: 567-578.","journal-title":"Cell"},{"key":"CITATION81","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1093\/emboj\/18.17.4608","volume":"18","author":"Pike AC","year":"1999","unstructured":"Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstr\u00f6m O, Ljunggren J, Gustafsson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J, 1999, 18: 4608-4618.","journal-title":"EMBO J"},{"key":"CITATION82","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1021\/ja202946k","volume":"133","author":"Phillips C","year":"2011","unstructured":"Phillips C, Roberts LR, Schade M, Bazin R, Bent A, Davies NL, Moore R, Pannifer AD, Pickford AR, Prior SH, Read CM, Scott A, Brown DG, Xu B, Irving SL. Design and structure of stapled peptides binding to estrogen receptors. J Am Chem Soc, 2011, 133: 9696-9699.","journal-title":"J Am Chem Soc"},{"key":"CITATION83","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1038\/s41598-017-03774-x","volume":"7","author":"Souza PCT","year":"2017","unstructured":"Souza PCT, Textor LC, Melo DC, Nascimento AS, Skaf MS, Polikarpov I. An alternative conformation of ER\u03b2 bound to estradiol reveals H12 in a stable antagonist position. Sci Rep, 2017, 7:","journal-title":"Sci Rep"},{"key":"CITATION84","doi-asserted-by":"publisher","first-page":"49330","DOI":"10.1074\/jbc.M407999200","volume":"279","author":"Kallen J","year":"2004","unstructured":"Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M, Fournier B. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor \u03b1 (ERR\u03b1). J Biol Chem, 2004, 279: 49330-49337.","journal-title":"J Biol Chem"},{"key":"CITATION85","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0022-2836(03)00183-9","volume":"327","author":"Gearhart MD","year":"2003","unstructured":"Gearhart MD, Holmbeck SMA, Evans RM, Dyson HJ, Wright PE. Monomeric complex of human orphan estrogen related receptor-2 with DNA: a pseudo-dimer interface mediates extended half-site recognition. J Mol Biol, 2003, 327: 819-832.","journal-title":"J Mol Biol"},{"key":"CITATION86","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1016\/j.jmb.2020.08.007","volume":"432","author":"Yao B","year":"2020","unstructured":"Yao B, Zhang S, Wei Y, Tian S, Lu Z, Jin L, He Y, Xie W, Li Y. Structural insights into the specificity of ligand binding and coactivator assembly by estrogen-related receptor \u03b2. J Mol Biol, 2020, 432: 5460-5472.","journal-title":"J Mol Biol"},{"key":"CITATION87","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1097-2765(02)00444-6","volume":"9","author":"Greschik H","year":"2002","unstructured":"Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D, Renaud JP. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol Cell, 2002, 9: 303-313.","journal-title":"Mol Cell"},{"key":"CITATION88","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/acs.chemrestox.9b00379","volume":"33","author":"Suyama K","year":"2020","unstructured":"Suyama K, Kaneko S, Kesamaru H, Liu X, Matsushima A, Kakuta Y, Okubo T, Kasatani K, Nose T. Evaluation of the influence of halogenation on the binding of bisphenol A to the estrogen-related receptor \u03b3. Chem Res Toxicol, 2020, 33: 889-902.","journal-title":"Chem Res Toxicol"},{"key":"CITATION89","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1007\/s00018-019-03129-x","volume":"76","author":"Thouennon E","year":"2019","unstructured":"Thouennon E, Delfosse V, Bailly R, Blanc P, Boulahtouf A, Grimaldi M, Barducci A, Bourguet W, Balaguer P. Insights into the activation mechanism of human estrogen-related receptor \u03b3 by environmental endocrine disruptors. Cell Mol Life Sci, 2019, 76: 4769-4781.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION90","doi-asserted-by":"publisher","first-page":"13497","DOI":"10.1038\/s41598-018-31812-9","volume":"8","author":"Frank F","year":"2018","unstructured":"Frank F, Okafor CD, Ortlund EA. The first crystal structure of a DNA-free nuclear receptor DNA binding domain sheds light on DNA-driven allostery in the glucocorticoid receptor. Sci Rep, 2018, 8:","journal-title":"Sci Rep"},{"key":"CITATION91","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/352497a0","volume":"352","author":"Luisi BF","year":"1991","unstructured":"Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature, 1991, 352: 497-505.","journal-title":"Nature"},{"key":"CITATION92","doi-asserted-by":"crossref","unstructured":"Meijsing SH, Pufall MA, So AY, Bates DL, Chen L, Yamamoto KR. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324: 407\u2013410.","DOI":"10.1126\/science.1164265"},{"key":"CITATION93","doi-asserted-by":"crossref","unstructured":"Hudson WH, Youn C, Ortlund EA. The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol 2013, 20: 53\u201358.","DOI":"10.1038\/nsmb.2456"},{"key":"CITATION94","doi-asserted-by":"crossref","unstructured":"Fagart J,  Huyet J, Pinon GM, Rochel M, Mayer C, Rafestin-Oblin ME. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol 2005, 12: 554\u2013555.","DOI":"10.1038\/nsmb939"},{"key":"CITATION95","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/1873-3468.13746","volume":"594","author":"Takahashi M","year":"2020","unstructured":"Takahashi M, Ubukata O, Homma T, Asoh Y, Honzumi M, Hayashi N, Saito K, Tsuruoka H, Aoki K, Hanzawa H. Crystal structure of the mineralocorticoid receptor ligand\u2010binding domain in complex with a potent and selective nonsteroidal blocker, esaxerenone (CS\u20103150). FEBS Lett, 2020, 594: 1615-1623.","journal-title":"FEBS Lett"},{"key":"CITATION96","doi-asserted-by":"publisher","first-page":"26164","DOI":"10.1074\/jbc.M004571200","volume":"275","author":"Matias PM","year":"2000","unstructured":"Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A, B\u00e4sler S, Sch\u00e4fer M, Egner U, Carrondo MA. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. J Biol Chem, 2000, 275: 26164-26171.","journal-title":"J Biol Chem"},{"key":"CITATION97","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/30775","volume":"393","author":"Williams SP","year":"1998","unstructured":"Williams SP, Sigler PB. Atomic structure of progesterone complexed with its receptor. Nature, 1998, 393: 392-396.","journal-title":"Nature"},{"key":"CITATION98","doi-asserted-by":"publisher","first-page":"20333","DOI":"10.1074\/jbc.M111.308403","volume":"287","author":"Lusher SJ","year":"2012","unstructured":"Lusher SJ, Raaijmakers HCA, Vu-Pham D, Kazemier B, Bosch R, McGuire R, Azevedo R, Hamersma H, Dechering K, Oubrie A, van Duin M, de Vlieg J. X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11\u03b2-substituted steroids. J Biol Chem, 2012, 287: 20333-20343.","journal-title":"J Biol Chem"},{"key":"CITATION99","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.1073\/pnas.081565498","volume":"98","author":"Sack JS","year":"2001","unstructured":"Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek Stanley R. J, Weinmann R, Einspahr HM. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A, 2001, 98: 4904-4909.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION100","doi-asserted-by":"crossref","unstructured":"Est\u00e9banez-Perpi\u00f1\u00e1 E, Arnold LA, Nguyen P, Rodrigues ED, Mar E, Bateman R, Pallai P, et al. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc Natl Acad Sci U S A 2007, 104: 16074-16079.","DOI":"10.1073\/pnas.0708036104"},{"key":"CITATION101","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1021\/acs.jmedchem.7b00373","volume":"60","author":"Unwalla R","year":"2017","unstructured":"Unwalla R, Mousseau JJ, Fadeyi OO, Choi C, Parris K, Hu B, Kenney T, Chippari S, McNally C, Vishwanathan K, Kilbourne E, Thompson C, Nagpal S, Wrobel J, Yudt M, Morris CA, Powell D, Gilbert AM, Chekler ELP. Structure-based approach to identify 5-[4-hydroxyphenyl]pyrrole-2-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. J Med Chem, 2017, 60: 6451-6457.","journal-title":"J Med Chem"},{"key":"CITATION102","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/8276","volume":"6","author":"Meinke G","year":"1999","unstructured":"Meinke G, Sigler PB. DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B.. Nat Struct Biol, 1999, 6: 471-477.","journal-title":"Nat Struct Biol"},{"key":"CITATION103","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nchembio.1069","volume":"8","author":"Zhan Y","year":"2012","unstructured":"Zhan Y, Chen Y, Zhang Q, Zhuang J, Tian M, Chen H, Zhang L, Zhang H, He J, Wang W, Wu R, Wang Y, Shi C, Yang K, Li A, Xin Y, Li TY, Yang JY, Zheng Z, Yu C, Lin SC, Chang C, Huang P, Lin T, Wu Q. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat Chem Biol, 2012, 8: 897-904.","journal-title":"Nat Chem Biol"},{"key":"CITATION104","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nchembio.1406","volume":"10","author":"Wang W","year":"2014","unstructured":"Wang W, Wang Y, Chen H, Xing Y, Li F, Zhang Q, Zhou B, Zhang H, Zhang J, Bian X, Li L, Liu Y, Zhao B, Chen Y, Wu R, Li A, Yao L, Chen P, Zhang Y, Tian X, Beermann F, Wu M, Han J, Huang P, Lin T, Wu Q. Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway. Nat Chem Biol, 2014, 10: 133-140.","journal-title":"Nat Chem Biol"},{"key":"CITATION105","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nchembio.1788","volume":"11","author":"Li L","year":"2015","unstructured":"Li L, Liu Y, Chen H, Li F, Wu J, Zhang H, He J, Xing Y, Chen Y, Wang W, Tian X, Li A, Zhang Q, Huang P, Han J, Lin T, Wu Q. Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation. Nat Chem Biol, 2015, 11: 339-346.","journal-title":"Nat Chem Biol"},{"key":"CITATION106","doi-asserted-by":"publisher","first-page":"27412","DOI":"10.1073\/pnas.2002997117","volume":"117","author":"Yang PB","year":"2020","unstructured":"Yang PB, Hou PP, Liu FY, Hong WB, Chen HZ, Sun XY, Li P, Zhang Y, Ju CY, Luo LJ, Wu SF, Zhou JX, Wang ZJ, He JP, Li L, Zhao TJ, Deng X, Lin T, Wu Q. Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Acad Sci U S A, 2020, 117: 27412-27422.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION107","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature01645","volume":"423","author":"Wang Z","year":"2003","unstructured":"Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NPC, Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature, 2003, 423: 555-560.","journal-title":"Nature"},{"key":"CITATION108","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41589-020-0553-6","volume":"16","author":"Rajan S","year":"2020","unstructured":"Rajan S, Jang Y, Kim CH, Kim W, Toh HT, Jeon J, Song B, Serra A, Lescar J, Yoo JY, Beldar S, Ye H, Kang C, Liu XW, Feitosa M, Kim Y, Hwang D, Goh G, Lim KL, Park HM, Lee CH, Oh SF, Petsko GA, Yoon HS, Kim KS. PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function. Nat Chem Biol, 2020, 16: 876-886.","journal-title":"Nat Chem Biol"},{"key":"CITATION109","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cell.2005.01.024","volume":"120","author":"Krylova IN","year":"2005","unstructured":"Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, Lebedeva L, Suzawa M, Williams JD, Williams SP, Guy RK, Thornton JW, Fletterick RJ, Willson TM, Ingraham HA. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell, 2005, 120: 343-355.","journal-title":"Cell"},{"key":"CITATION110","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1073\/pnas.1416740111","volume":"111","author":"Blind RD","year":"2014","unstructured":"Blind RD, Sablin EP, Kuchenbecker KM, Chiu HJ, Deacon AM, Das D, Fletterick RJ, Ingraham HA. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Proc Natl Acad Sci U S A, 2014, 111: 15054-15059.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION111","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S1097-2765(03)00236-3","volume":"11","author":"Sablin EP","year":"2003","unstructured":"Sablin EP, Krylova IN, Fletterick RJ, Ingraham HA. Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. Mol Cell, 2003, 11: 1575-1585.","journal-title":"Mol Cell"},{"key":"CITATION112","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1073\/pnas.1117036108","volume":"109","author":"Yumoto F","year":"2012","unstructured":"Yumoto F, Nguyen P, Sablin EP, Baxter JD, Webb P, Fletterick RJ. Structural basis of coactivation of liver receptor homolog-1 by -catenin. Proc Natl Acad Sci U S A, 2012, 109: 143-148.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION113","doi-asserted-by":"publisher","first-page":"18390","DOI":"10.1073\/pnas.0808936105","volume":"105","author":"Sablin EP","year":"2008","unstructured":"Sablin EP, Woods A, Krylova IN, Hwang P, Ingraham HA, Fletterick RJ. The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1. Proc Natl Acad Sci U S A, 2008, 105: 18390-18395.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION114","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1016\/j.jmb.2016.10.025","volume":"428","author":"Weikum ER","year":"2016","unstructured":"Weikum ER, Tuntland ML, Murphy MN, Ortlund EA. A structural investigation into oct4 regulation by orphan nuclear receptors, germ cell nuclear factor (GCNF), and liver receptor homolog-1 (LRH-1). J Mol Biol, 2016, 428: 4981-4992.","journal-title":"J Mol Biol"},{"key":"CITATION115","doi-asserted-by":"publisher","first-page":"24285","DOI":"10.1073\/pnas.2006890117","volume":"117","author":"Liu X","year":"2020","unstructured":"Liu X, Wang Y, Gutierrez JS, Damsker JM, Nagaraju K, Hoffman EP, Ortlund EA. Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A, 2020, 117: 24285-24293.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION116","doi-asserted-by":"publisher","first-page":"9505","DOI":"10.1073\/pnas.0501204102","volume":"102","author":"Li Y","year":"2005","unstructured":"Li Y, Choi M, Suino K, Kovach A, Daugherty J, Kliewer SA, Xu HE. Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner. Proc Natl Acad Sci U S A, 2005, 102: 9505-9510.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION117","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1073\/pnas.1322827111","volume":"111","author":"Zhi X","year":"2014","unstructured":"Zhi X, Zhou XE, He Y, Zechner C, Suino-Powell KM, Kliewer SA, Melcher K, Mangelsdorf DJ, Xu HE. Structural insights into gene repression by the orphan nuclear receptor SHP. Proc Natl Acad Sci U S A, 2014, 111: 839-844.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION118","doi-asserted-by":"crossref","unstructured":"Musille PM, Pathak M, Lauer JL, Hudson WJ, Griffin PR, Ortlund EA. Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation. Nat Struct Mol Biol 2012, 19: 532\u2013S2.","DOI":"10.1038\/nsmb.2279"},{"key":"CITATION119","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1042\/BJ20050872","volume":"391","author":"Lavery DN","year":"2005","unstructured":"Lavery DN, McEwan IJ. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J, 2005, 391: 449-464.","journal-title":"Biochem J"},{"key":"CITATION120","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/318635a0","volume":"318","author":"Hollenberg SM","year":"1985","unstructured":"Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Brad Thompson E, Rosenfeld MG, Evans RM. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature, 1985, 318: 635-641.","journal-title":"Nature"},{"key":"CITATION121","doi-asserted-by":"crossref","unstructured":"Huang P, Chandra V, Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol 2010, 72: 247\u2013272.","DOI":"10.1146\/annurev-physiol-021909-135917"},{"key":"CITATION122","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1210\/en.2016-1559","volume":"157","author":"Khorasanizadeh S","year":"2016","unstructured":"Khorasanizadeh S, Rastinejad F. Visualizing the architectures and interactions of nuclear receptors. Endocrinology, 2016, 157: 4212-4221.","journal-title":"Endocrinology"},{"key":"CITATION123","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1006\/jmbi.1999.3457","volume":"296","author":"Zhao Q","year":"2000","unstructured":"Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, Rastinejad F. Structural basis of RXR-DNA interactions 1 1Edited by P. E. Wright. J Mol Biol, 2000, 296: 509-520.","journal-title":"J Mol Biol"},{"key":"CITATION124","doi-asserted-by":"crossref","unstructured":"Osz J, McEwen AG, Poussin-Courmontagne P, Moutier E, Birck C, Davidson I, Moras D, et al. Structural basis of natural promoter recognition by the retinoid X nuclear receptor. Sci Rep 2015, 5: 8216.","DOI":"10.1038\/srep08216"},{"key":"CITATION125","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1021\/bi011086r","volume":"40","author":"Sierk ML","year":"2001","unstructured":"Sierk ML, Zhao Q, Rastinejad F. DNA deformability as a recognition feature in the reverb response element. Biochemistry, 2001, 40: 12833-12843.","journal-title":"Biochemistry"},{"key":"CITATION126","doi-asserted-by":"crossref","unstructured":"Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, et al. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019, 9: 1113\u20131144.","DOI":"10.1016\/j.apsb.2019.10.001"},{"key":"CITATION127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mce.2013.09.009","volume":"382","author":"Helsen C","year":"2014","unstructured":"Helsen C, Claessens F. Looking at nuclear receptors from a new angle. Mol Cell Endocrinol, 2014, 382: 97-106.","journal-title":"Mol Cell Endocrinol"},{"key":"CITATION128","doi-asserted-by":"crossref","unstructured":"Meyer CA, Tang Q, Liu XS. Minireview: applications of next-generation sequencing on studies of nuclear receptor regulation and function. Mol Endocrinol 2012, 26: 1651\u20131659.","DOI":"10.1210\/me.2012-1150"},{"key":"CITATION129","doi-asserted-by":"crossref","unstructured":"Li Y, Lambert MH, Xu HE. Activation of nuclear receptors: a perspective from structural genomics. Structure 2003, 11: 741\u2013746.","DOI":"10.1016\/S0969-2126(03)00133-3"},{"key":"CITATION130","doi-asserted-by":"crossref","unstructured":"Weatherman RV, Fletterick RJ, Scanlan TS. Nuclear-receptor ligands and ligand-binding domains. Annu Rev Biochem 199, 68: 559\u2013581.","DOI":"10.1146\/annurev.biochem.68.1.559"},{"key":"CITATION131","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMra041001","volume":"351","author":"Yki-J\u00e4rvinen H","year":"2004","unstructured":"Yki-J\u00e4rvinen H. Thiazolidinediones. N Engl J Med, 2004, 351: 1106-1118.","journal-title":"N Engl J Med"},{"key":"CITATION132","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"Nissen SE","year":"2007","unstructured":"Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med, 2007, 356: 2457-2471.","journal-title":"N Engl J Med"},{"key":"CITATION133","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00125-012-2777-9","volume":"56","author":"Zheng W","year":"2013","unstructured":"Zheng W, Feng X, Qiu L, Pan Z, Wang R, Lin S, Hou D, Jin L, Li Y. Identification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetes. Diabetologia, 2013, 56: 401-411.","journal-title":"Diabetologia"},{"key":"CITATION134","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/39645","volume":"389","author":"Brzozowski AM","year":"1997","unstructured":"Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstr\u00f6m O, \u00d6hman L, Greene GL, Gustafsson J\u00c5, Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 1997, 389: 753-758.","journal-title":"Nature"},{"key":"CITATION135","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/PL00000656","volume":"57","author":"Renaud JP","year":"2000","unstructured":"Renaud JP, Moras D. Structural studies on nuclear receptors. CMLS Cell Mol Life Sci, 2000, 57: 1748-1769.","journal-title":"CMLS Cell Mol Life Sci"},{"key":"CITATION136","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","volume":"10","author":"Moras D","year":"1998","unstructured":"Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol, 1998, 10: 384-391.","journal-title":"Curr Opin Cell Biol"},{"key":"CITATION137","doi-asserted-by":"crossref","unstructured":"Lee SK, Na SY, Kim HJ, Soh J, Choi HS, Lee JW. Identification of critical residues for heterodimerization within the ligand-binding domain of retinoid X receptor. Mol Endocrinol 1998, 12: 325\u2013332.","DOI":"10.1210\/mend.12.3.0072"},{"key":"CITATION138","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/375377a0","volume":"375","author":"Bourguet W","year":"1995","unstructured":"Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-\u03b1. Nature, 1995, 375: 377-382.","journal-title":"Nature"},{"key":"CITATION139","doi-asserted-by":"publisher","first-page":"11260","DOI":"10.1074\/jbc.274.16.11260","volume":"274","author":"Chen S","year":"1999","unstructured":"Chen S, Costa CH, Nakamura K, Ribeiro RCJ, Gardner DG. Vitamin D-dependent suppression of human atrial natriuretic peptide gene promoter activity requires heterodimer assembly. J Biol Chem, 1999, 274: 11260-11266.","journal-title":"J Biol Chem"},{"key":"CITATION140","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","volume":"110","author":"Bledsoe RK","year":"2002","unstructured":"Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell, 2002, 110: 93-105.","journal-title":"Cell"},{"key":"CITATION141","doi-asserted-by":"crossref","unstructured":"Sladek FM, Zhong WM, Lai E, Darnell Jr JE. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990, 4: 2353\u20132365.","DOI":"10.1101\/gad.4.12b.2353"},{"key":"CITATION142","doi-asserted-by":"crossref","unstructured":"Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, et al. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 2010, 51: 642\u2013653.","DOI":"10.1002\/hep.23357"},{"key":"CITATION143","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1128\/MCB.17.11.6546","volume":"17","author":"Jiang G","year":"1997","unstructured":"Jiang G, Lee U, Sladek FM. Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol Cell Biol, 1997, 17: 6546-6554.","journal-title":"Mol Cell Biol"},{"key":"CITATION144","doi-asserted-by":"crossref","unstructured":"Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 2000, 14: 2819\u20132830.","DOI":"10.1101\/gad.844900"},{"key":"CITATION145","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cmet.2005.03.001","volume":"1","author":"Kalaany NY","year":"2005","unstructured":"Kalaany NY, Gauthier KC, Zavacki AM, Mammen PPA, Kitazume T, Peterson JA, Horton JD, Garry DJ, Bianco AC, Mangelsdorf DJ. LXRs regulate the balance between fat storage and oxidation. Cell Metab, 2005, 1: 231-244.","journal-title":"Cell Metab"},{"key":"CITATION146","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/jnr.21038","volume":"84","author":"Hindinger C","year":"2006","unstructured":"Hindinger C, Hinton DR, Kirwin SJ, Atkinson RD, Burnett ME, Bergmann CC, Stohlman SA. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res, 2006, 84: 1225-1234.","journal-title":"J Neurosci Res"},{"key":"CITATION147","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1073\/pnas.172510899","volume":"99","author":"Wang L","year":"2002","unstructured":"Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci U S A, 2002, 99: 13878-13883.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION148","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/bcr3443","volume":"15","author":"Nguyen-Vu T","year":"2013","unstructured":"Nguyen-Vu T, Vedin LL, Liu K, Jonsson P, Lin JZ, Candelaria NR, Candelaria LP, Addanki S, Williams C, Gustafsson J\u00c5, Steffensen KR, Lin CY. Liver X receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism. Breast Cancer Res, 2013, 15:","journal-title":"Breast Cancer Res"},{"key":"CITATION149","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1053\/j.gastro.2013.02.005","volume":"144","author":"Lo Sasso G","year":"2013","unstructured":"Lo Sasso G, Bovenga F, Murzilli S, Salvatore L, Di Tullio G, Martelli N, D\u2032Orazio A, Rainaldi S, Vacca M, Mangia A, Palasciano G, Moschetta A. Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Gastroenterology, 2013, 144: 1497-1507.","journal-title":"Gastroenterology"},{"key":"CITATION150","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1073\/pnas.0806974105","volume":"105","author":"Fan X","year":"2008","unstructured":"Fan X, Kim HJ, Bouton D, Warner M, Gustafsson JA. Expression of liver X receptor   is essential for formation of superficial cortical layers and migration of later-born neurons. Proc Natl Acad Sci U S A, 2008, 105: 13445-13450.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION151","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1073\/pnas.0711599105","volume":"105","author":"Kim HJ","year":"2008","unstructured":"Kim HJ, Fan X, Gabbi C, Yakimchuk K, Parini P, Warner M, Gustafsson JA. Liver X receptor (LXR ): a link between-sitosterol and amyotrophic lateral sclerosis-Parkinson\u2032s dementia. Proc Natl Acad Sci U S A, 2008, 105: 2094-2099.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION152","doi-asserted-by":"publisher","first-page":"13112","DOI":"10.1073\/pnas.1210833109","volume":"109","author":"Dai Y","year":"2012","unstructured":"Dai Y, Tan X, Wu W, Warner M, Gustafsson J\u00c5. Liver X receptor   protects dopaminergic neurons in a mouse model of Parkinson disease. Proc Natl Acad Sci U S A, 2012, 109: 13112-13117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CITATION153","doi-asserted-by":"publisher","first-page":"33001","DOI":"10.1074\/jbc.M203572200","volume":"277","author":"Wansa KD","year":"2002","unstructured":"Wansa KD, Harris JM, Muscat GE. The activation function-1 domain of Nur77\/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J Biol Chem, 2002, 277: 33001-33011.","journal-title":"J Biol Chem"},{"key":"CITATION154","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/nar\/gkn941","volume":"37","author":"Lei N","year":"2009","unstructured":"Lei N, Zhang X, Chen H, Wang Y, Zhan Y, Zheng Z, Shen Y, Wu Q. A feedback regulatory loop between methyltransferase PRMT1 and orphan receptor TR3. Nucleic Acids Res, 2009, 37: 832-848.","journal-title":"Nucleic Acids Res"},{"key":"CITATION155","doi-asserted-by":"publisher","first-page":"44336","DOI":"10.1074\/jbc.M111.308999","volume":"286","author":"Kurakula K","year":"2011","unstructured":"Kurakula K, van der Wal E, Geerts D, van Tiel CM, de Vries CJ. FHL2 protein is a novel co-repressor of nuclear receptor Nur77. J Biol Chem, 2011, 286: 44336-44343.","journal-title":"J Biol Chem"},{"key":"CITATION156","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/carcin\/bgr287","volume":"33","author":"Yao L","year":"2012","unstructured":"Yao L, He J, Chen H, Wang Y, Wang W, Wu R, Yu C, Wu Q. Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesis. Curr Alzheimer Rescinogenesis, 2012, 33: 301-311.","journal-title":"Curr Alzheimer Rescinogenesis"},{"key":"CITATION157","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","volume":"137","author":"Saijo K","year":"2009","unstructured":"Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK. A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell, 2009, 137: 47-59.","journal-title":"Cell"},{"key":"CITATION158","doi-asserted-by":"crossref","unstructured":"van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development 2009, 136: 3205-3214.","DOI":"10.1242\/dev.033910"},{"key":"CITATION159","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrm2717","volume":"10","author":"Angers S","year":"2009","unstructured":"Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol, 2009, 10: 468-477.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION160","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1242\/jcs.013771","volume":"120","author":"Xu W","year":"2007","unstructured":"Xu W, Kimelman D. Mechanistic insights from structural studies of \u03b2-catenin and its binding partners. J Cell Sci, 2007, 120: 3337-3344.","journal-title":"J Cell Sci"},{"key":"CITATION161","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0092-8674(00)80352-9","volume":"90","author":"Huber AH","year":"1997","unstructured":"Huber AH, Nelson WJ, Weis WI. Three-dimensional structure of the armadillo repeat region of \u03b2-catenin. Cell, 1997, 90: 871-882.","journal-title":"Cell"},{"key":"CITATION162","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.str.2007.12.021","volume":"16","author":"Xing Y","year":"2008","unstructured":"Xing Y, Takemaru KI, Liu J, Berndt JD, Zheng JJ, Moon RT, Xu W. Crystal structure of a full-length \u03b2-catenin. Structure, 2008, 16: 478-487.","journal-title":"Structure"},{"key":"CITATION163","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.molcel.2004.07.009","volume":"15","author":"Botrugno OA","year":"2004","unstructured":"Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J, Schoonjans K. Synergy between LRH-1 and \u03b2-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell, 2004, 15: 499-509.","journal-title":"Mol Cell"},{"key":"CITATION164","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1210\/er.2003-0034","volume":"26","author":"Mulholland DJ","year":"2005","unstructured":"Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of nuclear receptors with the Wnt\/\u03b2-catenin\/TCF signaling axis: Wnt you like to know?. Endocrine Rev, 2005, 26: 898-915.","journal-title":"Endocrine Rev"},{"key":"CITATION165","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1074\/jbc.M111962200","volume":"277","author":"Yang F","year":"2002","unstructured":"Yang F, Li X, Sharma M, Sasaki CY, Longo DL, Lim B, Sun Z. Linking \u03b2-catenin to androgen-signaling pathway. J Biol Chem, 2002, 277: 11336-11344.","journal-title":"J Biol Chem"},{"key":"CITATION166","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jmb.2010.11.010","volume":"405","author":"Sun J","year":"2011","unstructured":"Sun J, Weis WI. Biochemical and structural characterization of \u03b2-catenin interactions with nonphosphorylated and CK2-phosphorylated Lef-1. J Mol Biol, 2011, 405: 519-530.","journal-title":"J Mol Biol"},{"key":"CITATION167","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nsb718","volume":"8","author":"Graham TA","year":"2001","unstructured":"Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W. TCF4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol, 2001, 8: 1048-1052.","journal-title":"Nat Struct Biol"},{"key":"CITATION168","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/er.2007-0012","volume":"28","author":"Lonard DM","year":"2007","unstructured":"Lonard DM, Lanz RB, O\u2032Malley BW. Nuclear receptor coregulators and human disease. Endocrine Rev, 2007, 28: 575-587.","journal-title":"Endocrine Rev"},{"key":"CITATION169","unstructured":"Xu PL, Shan SF, Kong YY, Xie YH, Wang Y. Characterization of a strong repression domain in the hinge region of orphan nuclear receptor hB1F\/hLRH-1. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 2003, 35: 909\u2013916."},{"key":"CITATION170","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/emboj.2011.475","volume":"31","author":"Nwachukwu JC","year":"2012","unstructured":"Nwachukwu JC, Nettles KW. The nuclear receptor signalling scaffold: insights from full-length structures. EMBO J, 2012, 31: 251-253.","journal-title":"EMBO J"},{"key":"CITATION171","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/emboj.2011.445","volume":"31","author":"Orlov I","year":"2012","unstructured":"Orlov I, Rochel N, Moras D, Klaholz BP. Structure of the full human RXR\/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO J, 2012, 31: 291-300.","journal-title":"EMBO J"},{"key":"CITATION172","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.molcel.2020.06.031","volume":"79","author":"Yu X","year":"2020","unstructured":"Yu X, Yi P, Hamilton RA, Shen H, Chen M, Foulds CE, Mancini MA, Ludtke SJ, Wang Z, O\u2032Malley BW. Structural insights of transcriptionally active, full-length androgen receptor coactivator complexes. Mol Cell, 2020, 79: 812-823.e4.","journal-title":"Mol Cell"},{"key":"CITATION173","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.molcel.2015.01.025","volume":"57","author":"Yi P","year":"2015","unstructured":"Yi P, Wang Z, Feng Q, Pintilie GD, Foulds CE, Lanz RB, Ludtke SJ, Schmid MF, Chiu W, O\u2032Malley BW. Structure of a biologically active estrogen receptor-coactivator complex on DNA. Mol Cell, 2015, 57: 1047-1058.","journal-title":"Mol Cell"},{"key":"CITATION174","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","volume":"69","author":"Guo Z","year":"2009","unstructured":"Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AMH, Edwards J, Qiu Y. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion\u2013resistant growth. Cancer Res, 2009, 69: 2305-2313.","journal-title":"Cancer Res"},{"key":"CITATION175","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1074\/jbc.270.13.7341","volume":"270","author":"Jenster G","year":"1995","unstructured":"Jenster G, van der Korput HA, Trapman J, Brinkmann AO. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem, 1995, 270: 7341-7346.","journal-title":"J Biol Chem"},{"key":"CITATION176","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/d41586-019-00879-3","volume":"567","author":"Scudellari M","year":"2019","unstructured":"Scudellari M. Protein-slaying drugs could be the next blockbuster therapies. Nature, 2019, 567: 298-300.","journal-title":"Nature"},{"key":"CITATION177","doi-asserted-by":"crossref","unstructured":"Jan M, Sperling AS, Ebert BL. Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide. Nat Rev Clin Oncol 2021, 18: 401\u2013417.","DOI":"10.1038\/s41571-021-00479-z"},{"key":"CITATION178","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/d41573-021-00052-4","volume":"20","author":"Mullard A","year":"2021","unstructured":"Mullard A. Targeted protein degraders crowd into the clinic. Nat Rev Drug Discov, 2021, 20: 247-250.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/A8FA17DE37A64462A5BD88B4E55A7241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2021001","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/A8FA17DE37A64462A5BD88B4E55A7241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T05:02:12Z","timestamp":1660021332000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2021001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,8]]},"published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2021001","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}